102 related articles for article (PubMed ID: 21498297)
1. Baseline incidence and severity of renal insufficiency evaluated by estimated glomerular filtration rates in patients scheduled for contrast-enhanced CT.
Utsunomiya D; Yanaga Y; Awai K; Oda S; Funama Y; Namimoto T; Yamashita Y
Acta Radiol; 2011 Jun; 52(5):581-6. PubMed ID: 21498297
[TBL] [Abstract][Full Text] [Related]
2. Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels.
Herts BR; Schneider E; Poggio ED; Obuchowski NA; Baker ME
Radiology; 2008 Jul; 248(1):106-13. PubMed ID: 18458249
[TBL] [Abstract][Full Text] [Related]
3. The incidence of contrast-induced nephropathy in trauma patients.
Hipp A; Desai S; Lopez C; Sinert R
Eur J Emerg Med; 2008 Jun; 15(3):134-9. PubMed ID: 18460952
[TBL] [Abstract][Full Text] [Related]
4. Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report.
Kim SM; Cha RH; Lee JP; Kim DK; Oh KH; Joo KW; Lim CS; Kim S; Kim YS
Am J Kidney Dis; 2010 Jun; 55(6):1018-25. PubMed ID: 20097462
[TBL] [Abstract][Full Text] [Related]
5. Contrast-induced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality.
Shema L; Ore L; Geron R; Kristal B
Isr Med Assoc J; 2009 Aug; 11(8):460-4. PubMed ID: 19891232
[TBL] [Abstract][Full Text] [Related]
6. Low-contrast dose protection protocol for diagnostic computed tomography in patients at high-risk for contrast-induced nephropathy.
Kidoh M; Nakaura T; Awai K; Matsunaga Y; Tanoue K; Harada K; Uemura S; Yamashita Y
J Comput Assist Tomogr; 2013; 37(2):289-96. PubMed ID: 23493222
[TBL] [Abstract][Full Text] [Related]
7. Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency.
Yoshida S; Kamihata H; Nakamura S; Senoo T; Manabe K; Motohiro M; Sugiura T; Iwasaka T
J Cardiol; 2009 Oct; 54(2):192-8. PubMed ID: 19782255
[TBL] [Abstract][Full Text] [Related]
8. Proteinuria as a predictor of renal dysfunction in trauma patients receiving intravenous contrast.
Clark JJ; Wong LL; Lurie F; Kamitaki BK
Am Surg; 2011 Sep; 77(9):1194-200. PubMed ID: 21944630
[TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
[TBL] [Abstract][Full Text] [Related]
10. Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention.
Conen D; Buerkle G; Perruchoud AP; Buettner HJ; Mueller C
Int J Cardiol; 2006 Jun; 110(2):237-41. PubMed ID: 16298441
[TBL] [Abstract][Full Text] [Related]
11. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
Nyman U; Björk J; Aspelin P; Marenzi G
Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
[TBL] [Abstract][Full Text] [Related]
12. Contrast induced nephropathy in patients undergoing intravenous (IV) contrast enhanced computed tomography (CECT) and the relationship with risk factors: a meta-analysis.
Moos SI; van Vemde DN; Stoker J; Bipat S
Eur J Radiol; 2013 Sep; 82(9):e387-99. PubMed ID: 23711425
[TBL] [Abstract][Full Text] [Related]
13. Diabetic patients with normal baseline renal function are at increased risk of developing contrast-induced nephropathy post-percutaneous coronary intervention.
Chong E; Poh KK; Shen L; Chai P; Tan HC
Singapore Med J; 2009 Mar; 50(3):250-4. PubMed ID: 19352566
[TBL] [Abstract][Full Text] [Related]
14. Contrast-induced nephrotoxicity in renal allograft recipients.
Ahuja TS; Niaz N; Agraharkar M
Clin Nephrol; 2000 Jul; 54(1):11-4. PubMed ID: 10939751
[TBL] [Abstract][Full Text] [Related]
15. Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions.
Chong E; Poh KK; Liang S; Soon CY; Tan HC
J Interv Cardiol; 2010 Oct; 23(5):451-9. PubMed ID: 20796168
[TBL] [Abstract][Full Text] [Related]
16. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease.
Pasqualini L; Schillaci G; Pirro M; Vaudo G; Siepi D; Innocente S; Ciuffetti G; Mannarino E
J Intern Med; 2007 Dec; 262(6):668-77. PubMed ID: 17908164
[TBL] [Abstract][Full Text] [Related]
17. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
[TBL] [Abstract][Full Text] [Related]
18. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists.
Reddan D; Fishman EK
Eur J Radiol; 2008 May; 66(2):235-45. PubMed ID: 17728089
[TBL] [Abstract][Full Text] [Related]
19. Under-recognized renal insufficiency in hospitalized patients: implications for care.
de Francisco AL; Fernandez E; Cruz JJ; Casas MT; Gómez-Gerique J; León A; Cava F; Bedini JL; Enguix A; Ripoll E; Borque LA; Fernandez A; Arias M
Eur J Intern Med; 2010 Aug; 21(4):327-32. PubMed ID: 20603046
[TBL] [Abstract][Full Text] [Related]
20. Moderate-severe renal insufficiency is a risk factor for sirolimus-eluting stent thrombosis. The RIFT study.
Zhu ZB; Zhang RY; Zhang Q; Zhang JS; Hu J; Yang ZK; Shen WF
Cardiology; 2009; 112(3):191-9. PubMed ID: 18682662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
